Cited by 432Genetic Associations and EpidemiologyCardiovascular Health and Risk FactorsCardiac electrophysiology and arrhythmias

The DOI matches its Crossref record; 85 of the 86 references it cites were found in a registry or an index.

Cardiovascular Disease

Open access

Nabel, Elizabeth G.·2003·New England Journal of Medicine

DOI 10.1056/nejmra035098

Open this paper in CoChat — free account Open PDF

Abstract

ardiovascular disease, including stroke, is the leading cause of illness and death in the United States.There are an estimated 62 million people with cardiovascular disease and 50 million people with hypertension in this country.1 In 2000, approximately 946,000 deaths were attributable to cardiovascular disease, accounting for 39 percent of all deaths in the United States. 2 Epidemiologic studies and randomized clinical trials have provided compelling evidence that coronary heart disease is largely preventable.3 However, there is also reason to believe that there is a heritable component to the disease.In this review, I highlight what we know now about genetic factors in cardiovascular disease.As future genomic discoveries are translated to the care of patients with cardiovascular disease, it is likely that what we can do will change.c lessons learned from monogenic cardiovascular disorders

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

Integrity signals

Registry

Crossref · 10.1056/nejmra035098

Cites

85 of 85 references verified0 citation errors · 0 not checkable

Statistics

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Major outcomes in high-risk hypertensive patients randomized to angiotensin-converting enzyme inhibitor or calcium channel blocker vs diuretic: the Antihypertensive and Lipid-Lowering Treatment to Prevent Heart Attack Trial (ALLHAT)
The ALLHAT Officers and Coordinators for the ALLHAT Collaborative Research Group (2002) · JAMA: The Journal of the American Medical Association · doi:10.1001/jama.288.23.2981 · Cited by 5,664
A mechanistic link between an inherited and an acquird cardiac arrthytmia: HERG encodes the IKr potassium channel
Sanguinetti, M. C., Jiang, C., Curran, M. E., & Keating, M. T. (1995) · Cell · doi:10.1016/0092-8674(95)90340-2 · Cited by 2,422
Prevalence of Hypertrophic Cardiomyopathy in a General Population of Young Adults
Maron, B. J., Gardin, J. M., Flack, J. M., Gidding, S. S., Kurosaki, T., & Bild, D. E. (1995) · Circulation · doi:10.1161/01.cir.92.4.785 · Cited by 2,274
Genetic basis and molecular mechanism for idiopathic ventricular fibrillation
Chen, Q., Kirsch, G. E., Zhang, D., Brugada, R., Brugada, J., Brugada, P., Potenza, D. R., Moya‐Mitjans, À., Borggrefe, M., BREITHARDT, G. E., et al. (1998) · Nature · doi:10.1038/32675 · Cited by 1,823
Pharmacogenomics — Drug Disposition, Drug Targets, and Side Effects
Evans, W. E., & McLeod, H. L. (2003) · New England Journal of Medicine · doi:10.1056/nejmra020526 · Cited by 1,778
Coassembly of KVLQT1 and minK (IsK) proteins to form cardiac IKS potassium channel
Sanguinetti, M. C., Curran, M. E., Zou, A., Shen, J., Specter, P. S., Atkinson, D. L., & Keating, M. T. (1996) · Nature · doi:10.1038/384080a0 · Cited by 1,765
Molecular Mechanisms of Human Hypertension
Lifton, R. P., Gharavi, A. G., & Geller, D. S. (2001) · Cell · doi:10.1016/s0092-8674(01)00241-0 · Cited by 1,686
SCN5A mutations associated with an inherited cardiac arrhythmia, long QT syndrome
Wang, Q. K., Shen, J., Splawski, I., Atkinson, D. L., Li, Z., Robinson, J. L., Moss, A. J., Towbin, J. A., & Keating, M. T. (1995) · Cell · doi:10.1016/0092-8674(95)90359-3 · Cited by 1,682
Accumulation of Dietary Cholesterol in Sitosterolemia Caused by Mutations in Adjacent ABC Transporters
Berge, K. E., Tian, H., Graf, G. A., Yu, L., Grishin, N. V., Schultz, J. R., Kwiterovich, P. O., Shan, B., Barnes, R., & Hobbs, H. H. (2000) · Science · doi:10.1126/science.290.5497.1771 · Cited by 1,645
KvLQT1 and IsK (minK) proteins associate to form the IKS cardiac potassium current
Barhanin, J., Lesage, F., Guillemare, E., Fink, M., Lazdunski, M., & Romey, G. (1996) · Nature · doi:10.1038/384078a0 · Cited by 1,613
Characterization of single-nucleotide polymorphisms in coding regions of human genes
Cargill, M., Altshuler, D., Ireland, J., Sklar, P., Ardlie, K., Patil, N., Lane, C. R., Lim, E. P., Kalyanaraman, N., Nemesh, J., et al. (1999) · Nature Genetics · doi:10.1038/10290 · Cited by 1,547
Human Hypertension Caused by Mutations in WNK Kinases
Wilson, F. H., Disse-Nicodème, S., Choate, K. A., Ishikawa, K., Nelson-Williams, C. J., Desitter, I., Günel, M., Milford, D. V., Lipkin, G. W., Achard, J., et al. (2001) · Science · doi:10.1126/science.1062844 · Cited by 1,466
A molecular basis for familial hypertrophic cardiomyopathy: A β cardiac myosin heavy chain gene missense mutation
Geisterfer-Lowrance, A. A. T., Kass, S., Tanigawa, G., Vosberg, H.-P., McKenna, W., Seidman, C. E., & Seidman, J. G. (1990) · Cell · doi:10.1016/0092-8674(90)90274-i · Cited by 1,380
MiRP1 Forms IKr Potassium Channels with HERG and Is Associated with Cardiac Arrhythmia
Abbott, G. W., Sesti, F., Splawski, I., Buck, M. E., Lehmann, M. H., Timothy, K. W., Keating, M. T., & Goldstein, S. A. N. (1999) · Cell · doi:10.1016/s0092-8674(00)80728-x · Cited by 1,353
Liddle's syndrome: Heritable human hypertension caused by mutations in the β subunit of the epithelial sodium channel
Shimkets, R. A., Warnock, D. G., Bositis, C. M., Nelson-Williams, C. J., Hansson, J. H., Schambelan, M., Gill, J. R., Ulick, S., Milora, R. V., Findling, J. W., et al. (1994) · Cell · doi:10.1016/0092-8674(94)90250-x · Cited by 1,256
Venous thrombosis due to poor anticoagulant response to activated protein C: Leiden Thrombophilia Study
Koster, T., Vandenbroucke, J. P., Rosendaal, F. R., de Ronde, H., Briët, E., & Bertina, R. M. (1993) · The Lancet · doi:10.1016/s0140-6736(05)80081-9 · Cited by 1,236
Spectrum of Mutations in Long-QT Syndrome Genes
Splawski, I., Shen, J., Timothy, K. W., Lehmann, M. H., Priori, S. G., Robinson, J. L., Moss, A. J., Schwartz, P. J., Towbin, J. A., Vincent, G. M., et al. (2000) · Circulation · doi:10.1161/01.cir.102.10.1178 · Cited by 1,231
Gitelman's variant of Barter's syndrome, inherited hypokalaemic alkalosis, is caused by mutations in the thiazide-sensitive Na–Cl cotransporter
Simon, D. B., Nelson-Williams, C. J., BIA, M. J., Ellison, D. H., Karet, F. E., Molina, A. M., Vaara, I., Iwata, F., Cushner, H. M., Koolen, M. I., et al. (1996) · Nature Genetics · doi:10.1038/ng0196-24 · Cited by 1,206
A chimaeric llβ-hydroxylase/aldosterone synthase gene causes glucocorticoid-remediable aldosteronism and human hypertension
Lifton, R. P., Dluhy, R. G., Powers, M., Rich, G. M., Cook, S., Ulick, S., & Lalouel, J.-M. (1992) · Nature · doi:10.1038/355262a0 · Cited by 1,158
Resistance to Activated Protein C as a Basis for Venous Thrombosis
Svensson, P. J., & Dahlbäck, B. (1994) · New England Journal of Medicine · doi:10.1056/nejm199402243300801 · Cited by 1,127
The Genetic Basis for Cardiomyopathy
Seidman, J. G., & Seidman, C. E. (2001) · Cell · doi:10.1016/s0092-8674(01)00242-2 · Cited by 1,050
Inheritance and Drug Response
Weinshilboum, R. M. (2003) · New England Journal of Medicine · doi:10.1056/nejmra020021 · Cited by 1,032
Mutation in the Gene Coding for Coagulation Factor V and the Risk of Myocardial Infarction, Stroke, and Venous Thrombosis in Apparently Healthy Men
Ridker, P. M., Hennekens, C. H., Lindpaintner, K., Stampfer, M. J., Eisenberg, P. R., & Miletich, J. P. (1995) · New England Journal of Medicine · doi:10.1056/nejm199504063321403 · Cited by 1,031
Molecular and Cellular Mechanisms of Cardiac Arrhythmias
Keating, M. T., & Sanguinetti, M. C. (2001) · Cell · doi:10.1016/s0092-8674(01)00243-4 · Cited by 1,003
High risk of thrombosis in patients homozygous for factor V Leiden (activated protein C resistance) [see comments]
Rosendaal, F. R., Koster, T., Vandenbroucke, J. P., & Reitsma, P. H. (1995) · Blood · doi:10.1182/blood.v85.6.1504.bloodjournal8561504 · Cited by 999
Complex promoter and coding region β 2 -adrenergic receptor haplotypes alter receptor expression and predict in vivo responsiveness
Drysdale, C. M., McGraw, D. W., Stack, C. B., Stephens, J. C., Judson, R., Nandabalan, K., Arnold, K., Ruaño, G., & Liggett, S. B. (2000) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.97.19.10483 · Cited by 959
Molecular mechanism for an inherited cardiac arrhythmia
Bennett, P. B., Yazawa, K., Makita, N., & George, A. L. (1995) · Nature · doi:10.1038/376683a0 · Cited by 952
The proliferation gene expression signature is a quantitative integrator of oncogenic events that predicts survival in mantle cell lymphoma
Rosenwald, A., Wright, G. W., Wiestner, A. U., Chan, W. C., Connors, J. M., Campo, E., Gascoyne, R. D., Grogan, T. M., Müller-Hermelink, H. K., Smeland, E. B., et al. (2003) · Cancer Cell · doi:10.1016/s1535-6108(03)00028-x · Cited by 913
Bartter's syndrome, hypokalaemic alkalosis with hypercalciuria, is caused by mutations in the Na–K–2CI cotransporter NKCC2
Simon, D. B., Karet, F. E., Hamdan, J. M., Pietro, A. D., Sanjad, S. A., & Lifton, R. P. (1996) · Nature Genetics · doi:10.1038/ng0696-183 · Cited by 902
Finding genes that underlie complex traits.
Glazier, A. M., Nadeau, J. H., & Aitman, T. J. (2002) · Science · doi:10.1126/science.1076641 · Cited by 855
Trends and Disparities in Coronary Heart Disease, Stroke, and Other Cardiovascular Diseases in the United States
Cooper, R., Cutler, J. A., Desvigne-Nickens, P. M., Fortmann, S. P., Friedman, L., Havlik, R. J., Hogelin, G. C., Marler, J. M., McGovern, P. C., Morosco, G. J., et al. (2000) · Circulation · doi:10.1161/01.cir.102.25.3137 · Cited by 831
Mutations in the Gene for Cardiac Myosin-Binding Protein C and Late-Onset Familial Hypertrophic Cardiomyopathy
Niimura, H., Bachinski, L. L., Sangwatanaroj, S., Watkins, H. C., Chudley, A. E., McKenna, W. J., Kristinsson, A., Roberts, R., Sole, M. J., Maron, B. J., et al. (1998) · New England Journal of Medicine · doi:10.1056/nejm199804303381802 · Cited by 757
Mutations in Sarcomere Protein Genes as a Cause of Dilated Cardiomyopathy
Kamisago, M., Sharma, S. D., DePalma, S. R., Solomon, S., Sharma, P., McDonough, B., Smoot, L., Mullen, M. P., Woolf, P. K., Wigle, E. D., et al. (2000) · New England Journal of Medicine · doi:10.1056/nejm200012073432304 · Cited by 720
Prediction of the Risk of Myocardial Infarction from Polymorphisms in Candidate Genes
Yamada, Y., Izawa, H., Ichihara, S., Takatsu, F., Ishihara, H., Hirayama, H., Sone, T., Tanaka, M., & Yokota, M. (2002) · New England Journal of Medicine · doi:10.1056/nejmoa021445 · Cited by 639
Cardiac conduction defects associate with mutations in SCN5A
Schott, J., Alshinawi, C., Kyndt, F., Probst, V., Hoorntje, T. M., Hulsbeek, M. M. F., Wilde, A. A. M., Escande, D., Mannens, M. M. A. M., & Marec, H. L. (1999) · Nature Genetics · doi:10.1038/12618 · Cited by 634
Primary structure and functional expression of the human cardiac tetrodotoxin-insensitive voltage-dependent sodium channel.
Gellens, M., George, A. L., Chen, L. Q., Chahine, M., HORN, R. C. V., Barchi, R. L., & Kallen, R. G. (1992) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.89.2.554 · Cited by 628
Autosomal Recessive Hypercholesterolemia Caused by Mutations in a Putative LDL Receptor Adaptor Protein
Garcia, C. K., Wilund, K., Arca, M., Zuliani, G., Fellin, R., Maioli, M., Calandra, S., Bertolini, S., Cossu, F., Grishin, N., et al. (2001) · Science · doi:10.1126/science.1060458 · Cited by 624
The Role of a Common Variant of the Cholesteryl Ester Transfer Protein Gene in the Progression of Coronary Atherosclerosis
Kuivenhoven, J. A., Jukema, J. W., Zwinderman, A. H., de Knijff, P., McPherson, R., Bruschke, A. V. G., Lie, K. I., & Kastelein, J. J. P. (1998) · New England Journal of Medicine · doi:10.1056/nejm199801083380203 · Cited by 623
Functional polymorphisms of the human multidrug-resistance gene: Multiple sequence variations and correlation of one allele with P-glycoprotein expression and activity in vivo
Hoffmeyer, S. (2000) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.050585397 · Cited by 599
Mutations in the cardiac troponin I gene associated with hypertrophic cardiomyopathy
Kimura, A., Harada, H., Park, J.-E., Nishi, H., Satoh, M., Takahashi, M., Hiroi, S., Sasaoka, T., Ohbuchi, N., Nakamura, T., et al. (1997) · Nature Genetics · doi:10.1038/ng0897-379 · Cited by 576
Variant of SCN5A Sodium Channel Implicated in Risk of Cardiac Arrhythmia
Splawski, I., Timothy, K. W., Tateyama, M., Clancy, C. E., Malhotra, A., Beggs, A. H., Cappuccio, F. P., Sagnella, G. A., Kass, R. S., & Keating, M. T. (2002) · Science · doi:10.1126/science.1073569 · Cited by 526
Synergistic Polymorphisms of β1- and α2C-Adrenergic Receptors and the Risk of Congestive Heart Failure
Small, K. M., Wagoner, L. E., Levin, A. M., Kardia, S. L. R., & Liggett, S. B. (2002) · New England Journal of Medicine · doi:10.1056/nejmoa020803 · Cited by 524
A common polymorphism associated with antibiotic-induced cardiac arrhythmia
Sesti, F., Abbott, G. W., Wei, J., Murray, K. T., Saksena, S. V., Schwartz, P. J., Priori, S. G., Roden, D. M., George, A. L., & Goldstein, S. A. N. (2000) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.180223197 · Cited by 479
BeadArray ™ Technology: Enabling an Accurate, Cost-Effective Approach to High-Throughput Genotyping
Oliphant, A., Barker, D. L. A., Stuelpnagel, J., & Chee, M. S. (2002) · BioTechniques · doi:10.2144/jun0207 · Cited by 462
Activated protein C resistance as an additional risk factor for thrombosis in protein C-deficient families
Koeleman, B. P. C., Reitsma, P. H., Allaart, C. F., & Bertina, R. M. (1994) · Blood · doi:10.1182/blood.v84.4.1031.1031 · Cited by 442
Anticoagulant protein C pathway defective in majority of thrombophilic patients [see comments]
Griffin, J. H., Evatt, B. L., Wideman, C. S., & Fernandez, J. (1993) · Blood · doi:10.1182/blood.v82.7.1989.1989 · Cited by 415
A sodium-channel mutation causes isolated cardiac conduction disease
Tan, H. L., Bink‐Boelkens, M. T. E., Bezzina, C. R., Viswanathan, P. C., Beaufort‐Krol, G. C. M., van Tintelen, J. P., van den Berg, M. P., Wilde, A. A. M., & Balser, J. R. (2001) · Nature · doi:10.1038/35059090 · Cited by 398
A de novo missense mutation of the beta subunit of the epithelial sodium channel causes hypertension and Liddle syndrome, identifying a proline-rich segment critical for regulation of channel activity.
Hansson, J. H., Schild, L., Lu, Y., Wilson, T. A., Gautschi, I., Shimkets, R. A., Nelson-Williams, C. J., Rossier, B. C., & Lifton, R. P. (1995) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.92.25.11495 · Cited by 365
The Effect of Common Polymorphisms of the β2-Adrenergic Receptor on Agonist-Mediated Vascular Desensitization
Dishy, V., Sofowora, G. G., Xie, H., Kim, R. B., Byrne, D. W., Stein, C. M., & Wood, A. J. J. (2001) · New England Journal of Medicine · doi:10.1056/nejmoa010819 · Cited by 363
Hereditary hypertension caused by chimaeric gene duplications and ectopic expression of aldosterone synthase
Lifton, R. P., Dluhy, R. G., Powers, M., Rich, G. M., Gutkin, M. C., Fallo, F., Gill, J. R., Feld, L. G., Ganguly, A., Laidlaw, J. C., et al. (1992) · Nature Genetics · doi:10.1038/ng0992-66 · Cited by 329
MDR1 Genotype-Related Pharmacokinetics of Digoxin After Single Oral Administration in Healthy Japanese Subjects
Sakaeda, T., Nakamura, T., Horinouchi, M., Kakumoto, M., Ohmoto, N., Sakai, T., Morita, Y., Tamura, T., Aoyama, N., Hirai, M., et al. (2001) · Pharmaceutical Research · doi:10.1023/a:1012244520615 · Cited by 322
Role of the deletion of polymorphism of the angiotensin converting enzyme gene in the progression and therapeutic responsiveness of IgA nephropathy.
Yoshida, H., Mitarai, T., Kawamura, T., KITAJIMA, T., Miyazaki, Y., Nagasawa, R., Kawaguchi, Y., Kubo, H., Ichikawa, I., & Sakai, O. (1995) · Journal of Clinical Investigation · doi:10.1172/jci118270 · Cited by 318
Resistance to activated protein C as an additional genetic risk factor in hereditary deficiency of protein S
Zöller, B., Berntsdotter, A., de Frutos, P. G., & Dahlbäck, B. (1995) · Blood · doi:10.1182/blood.v85.12.3518.bloodjournal85123518 · Cited by 302
Single Nucleotide Polymorphisms in Multiple Novel Thrombospondin Genes May Be Associated With Familial Premature Myocardial Infarction
Topol, E. J., McCarthy, J. J., Gabriel, S., Moliterno, D. J., Rogers, W. J., Newby, L. K., Freedman, M., Metivier, J., Cannata, R., O’Donnell, C. J., et al. (2001) · Circulation · doi:10.1161/hc4701.100910 · Cited by 282
The Cholesterol Quartet
Goldstein, J. L., & Brown, M. S. (2001) · Science · doi:10.1126/science.1061815 · Cited by 241
The Apolipoprotein ε4 Allele Determines Prognosis and the Effect on Prognosis of Simvastatin in Survivors of Myocardial Infarction
Gerdes, L. U., Gerdes, C., Kervinen, K., Savolainen, M. J., Klausen, I. C., HANSEN, P. S., Kesäniemi, Y. A., & Færgeman, O. (2000) · Circulation · doi:10.1161/01.cir.101.12.1366 · Cited by 235
Factor V Leiden (FV R506Q) in Families with Inherited Antithrombin Deficiency
van Boven, H. H., Reitsma, P. H., Rosendaal, F. R., Bayston, T. A., Chowdhury, V., Borg, J. Y., Bauer, K. A., Scharrer, I., Conard, J., & Lane, D. A. (1996) · Thrombosis and Haemostasis · doi:10.1055/s-0038-1650289 · Cited by 227
Genotype-phenotype correlations in hypertrophic cardiomyopathy. Insights provided by comparisons of kindreds with distinct and identical beta-myosin heavy chain gene mutations.
Fananapazir, L., & Epstein, N. D. (1994) · Circulation · doi:10.1161/01.cir.89.1.22 · Cited by 226
Angiotensin-I Converting Enzyme Genotypes and Left Ventricular Hypertrophy in Patients With Hypertrophic Cardiomyopathy
Lechin, M. E., Quiñones, M. A., Omran, A., Hill, R., Yu, Q., Rakowski, H., Wigle, D., Liew, C. C., Sole, M. J., Roberts, R., et al. (1995) · Circulation · doi:10.1161/01.cir.92.7.1808 · Cited by 210
Pharmacogenetic Interactions Between β-Blocker Therapy and the Angiotensin-Converting Enzyme Deletion Polymorphism in Patients With Congestive Heart Failure
McNamara, D. M., Holubkov, R., Janosko, K. M., Palmer, A., Wang, J. J., MacGowan, G. A., Murali, S., Rosenblum, W. D., London, B., & Feldman, A. M. (2001) · Circulation · doi:10.1161/01.cir.103.12.1644 · Cited by 192
Apolipoprotein E genotype affects plasma lipid response to atorvastatin in a gender specific manner
Pedro‐Botet, J., Schaefer, E. J., Bakker-Arkema, R. G., Black, D. M., Stein, E., Corella, D., & Ordovás, J. M. (2001) · Atherosclerosis · doi:10.1016/s0021-9150(01)00410-5 · Cited by 173
β 2 -Adrenoceptor Polymorphism Determines Vascular Reactivity in Humans
Cockcroft, J. R., Gazis, A., Cross, D. J., Wheatley, A. P., Dewar, J. C., Hall, I. P., & Noon, J. P. (2000) · Hypertension · doi:10.1161/01.hyp.36.3.371 · Cited by 160
Effect of angiotensin-converting enzyme (ACE) gene polymorphism on progression of renal disease and the influence of ACE inhibition in IDDM patients: findings from the EUCLID Randomized Controlled Trial. EURODIAB Controlled Trial of Lisinopril in IDDM.
Penno, G., Chaturvedi, N., Talmud, P. J., Cotroneo, P., Manto, A., Nannipieri, M., Luong, L. A., & Fuller, J. (1998) · Diabetes · doi:10.2337/diabetes.47.9.1507 · Cited by 160
Homozygous Mutation in Cardiac Troponin T
Ho, C. Y., Lever, H. M., DeSanctis, R. W., Farver, C. F., Seidman, J. G., & Seidman, C. E. (2000) · Circulation · doi:10.1161/01.cir.102.16.1950 · Cited by 150
Insertion-Deletion Polymorphism of the ACE Gene Modulates Reversibility of Endothelial Dysfunction With ACE Inhibition
Prasad, A., Narayanan, S. N., Husain, S., Padder, F. A., Waclawiw, M. A., Epstein, N., & Quyyumi, A. A. (2000) · Circulation · doi:10.1161/01.cir.102.1.35 · Cited by 133
β2-Adrenergic Receptor Pharmacogenetics
Liggett, S. B. (2000) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/ajrccm.161.supplement_2.a1q4-10 · Cited by 130
Identification of genes differentially expressed in breast cancer cells treated with tamoxifen, using microarray-based expression profiling
Lee, A., Krishnasamy, A., Epstein, R. J., & Hong, G. S. (2001) · Nature Genetics · doi:10.1038/87170 · Cited by 126
Gene Expression Profiling of Human Stent-Induced Neointima by cDNA Array Analysis of Microscopic Specimens Retrieved by Helix Cutter Atherectomy
Zohlnhöfer, D., Klein, C. A., Richter, T., Brandl, R., Murr, A., Nührenberg, T. G., Schömig, A., Baeuerle, P. A., & Neumann, F. (2001) · Circulation · doi:10.1161/01.cir.103.10.1396 · Cited by 125
Left Ventricular Hypertrophy With Exercise and ACE Gene Insertion/Deletion Polymorphism
Myerson, S. G., Montgomery, H., Whittingham, M., Jubb, M., WORLD, M. J., Humphries, S. E., & Pennell, D. J. (2001) · Circulation · doi:10.1161/01.cir.103.2.226 · Cited by 124
AT 1 Receptor A/C 1166 Polymorphism Contributes to Cardiac Hypertrophy in Subjects With Hypertrophic Cardiomyopathy
Osterop, A. P. R. M., Kofflard, M. J. M., Sandkuijl, L. A., ten Cate, F. J., Krams, R., Schalekamp, M. A. D. H., & Danser, A. H. J. (1998) · Hypertension · doi:10.1161/01.hyp.32.5.825 · Cited by 122
Variability of Thrombosis among Homozygous Siblings with Resistance to Activated Protein C Due to an Arg-to-Gln Mutation in the Gene for Factor V
Greengard, J. S., Eichinger, S., Griffin, J. H., & Bauer, K. A. (1994) · New England Journal of Medicine · doi:10.1056/nejm199412083312305 · Cited by 119
The Influence of the Angiotensin I Converting Enzyme Genotype in Familial Hypertrophic Cardiomyopathy Varies with the Disease Gene Mutation
Tesson, F., Dufour, C., Moolman, J. C., Carrier, L., Al‐Mahdawi, S., Chojnowska, L., Dubourg, O., Soubrier, F., Brink, P. A., Michel Komajda, N., et al. (1997) · Journal of Molecular and Cellular Cardiology · doi:10.1006/jmcc.1996.0332 · Cited by 118
Genetic polymorphisms in the renin-angiotensin-aldosterone system associated with expression of left ventricular hypertrophy in hypertrophic cardiomyopathy: a study of five polymorphic genes in a family with a disease causing mutation in the myosin binding protein C gene
Ortlepp, J. R., Vosberg, H. P., Reith, S., Ohme, F., Mahon, N. G., Schröder, D., Klues, H. G., Hanrath, P., & McKenna, W. J. (2002) · Heart · doi:10.1136/heart.87.3.270 · Cited by 111
High-throughput screening for evidence of association by using mass spectrometry genotyping on DNA pools
Mohlke, K. L., Erdos, M. R., Scott, L. J., Fingerlin, T. E., Jackson, A., Silander, K., Hollstein, P. E., Boehnke, M., & Collins, F. S. (2002) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.262661399 · Cited by 105
Impact of Laboratory Molecular Diagnosis on Contemporary Diagnostic Criteria for Genetically Transmitted Cardiovascular Diseases: Hypertrophic Cardiomyopathy, Long-QT Syndrome, and Marfan Syndrome
Maron, B. J., Moller, J. H., Seidman, C. E., Vincent, G. M., Dietz, H. C., Moss, A. J., Towbin, J. A., Sondheimer, H. M., Pyeritz, R. E., McGee, G., et al. (1998) · Circulation · doi:10.1161/01.cir.98.14.1460 · Cited by 103
Transcriptome analysis reveals a role of interferon-gamma in human neointima formation.
Zohlnhöfer, D., Richter, T., Neumann, F., Nührenberg, T., Wessely, R., Brandl, R., Murr, A., Klein, C., & Baeuerle, P. (2001) · Molecules and Cells · doi:10.1016/s1097-2765(01)00239-8 · Cited by 99
Predicting Response to Chronic Antihypertensive Treatment with Fosinopril: The Role of Angiotensin-Converting Enzyme Gene Polymorphism
Stavroulakis, G. A., Makris, T. K., Krespi, P. G., Hatzizacharias, A. N., Gialeraki, A. E., Anastasiadis, G., Triposkiadis, P., & Kyriakidis, M. (2000) · Cardiovascular Drugs and Therapy · doi:10.1023/a:1007820401377 · Cited by 94
Apolipoprotein E genotypes and response of plasma lipids and progression–regression of coronary atherosclerosis to lipid-lowering drug therapy
Ballantyne, C. M., Herd, J. A., Stein, E. A., Ferlic, L. L., Dunn, J. K., Gotto, A. M., & Marian, A. J. (2000) · Journal of the American College of Cardiology · doi:10.1016/s0735-1097(00)00918-9 · Cited by 92
ACE genotype and ACE inhibitors induced renoprotection in chronic proteinuric nephropathies1
Perna, A., (GISEN), F. T. G. I. D. S. E. I. N., Ruggenenti, P. L., Testa, A., Spoto, B., Benini, R., Misefari, V., Remuzzi, G., & Zoccali, C. (2000) · Kidney International · doi:10.1046/j.1523-1755.2000.00818.x · Cited by 91
The risk of recurrent venous thromboembolism among heterozygous carriers of the G20210A prothrombin gene mutation
Stefano, V. D., Martinelli, I., Mannucci, P. M., Paciaroni, K., Rossi, E., Chiusolo, P., Casorelli, I., & Leone, G. G. M. (2001) · British Journal of Haematology · doi:10.1046/j.1365-2141.2001.02827.x · Cited by 90
Effect of the Insertion/Deletion Polymorphism of the Angiotensin-Converting Enzyme Gene on Response to Angiotensin-Converting Enzyme Inhibitors in Patients with Heart Failure
O’Toole, L., Stewart, M., Padfield, P. L., & Channer, K. S. (1998) · Journal of Cardiovascular Pharmacology · doi:10.1097/00005344-199812000-00017 · Cited by 82
Association between angiotensin-converting enzyme gene polymorphisms and regression of left ventricular hypertrophy in patients treated with angiotensin-converting enzyme inhibitors
Kohno, M., Yokokawa, K., Minami, M., Kano, H., Yasunari, K., Hanehira, T., & Yoshikawa, J. (1999) · The American Journal of Medicine · doi:10.1016/s0002-9343(99)00067-4 · Cited by 79
Interactions between angiotensin-I converting enzyme insertion/deletion polymorphism and response of plasma lipids and coronary atherosclerosis to treatment with fluvastatin
Marian, A. J., Safavi, F., Ferlic, L. L., Dunn, J. K., Gotto, A. M., & Ballantyne, C. M. (2000) · Journal of the American College of Cardiology · doi:10.1016/s0735-1097(99)00535-5 · Cited by 73
New Concepts in Hypertrophic Cardiomyopathies, Part I
Roberts, R., & Sigwart, U. (2001) · Circulation · doi:10.1161/hc4201.097429 · Cited by 70
Congenitally defective aldosterone biosynthesis in humans: The involvement of point mutations of the P-450C18 gene (CYP11B2) in CMO II deficient patients
Mitsuuchi, Y., Kawamoto, T., Rösler, A., Naiki, Y., Miyahara, K., Toda, K., Kuribayashi, I., Orii, T., Yasuda, K., Miura, K., et al. (1992) · Biochemical and Biophysical Research Communications · doi:10.1016/0006-291x(92)91827-d · Cited by 55

Research works printed but not linked: 3

Goldstein JL, Hobbs HH, Brown MS. Familial hypercholesterolemia. In: Scriver CR, Beaudet AL, Sly WS, Valle D, eds. The metabolic & molecular bases of inherited disease. 8th ed. Vol. 2. New York: McGraw-Hill, 2001:2863-913.
Kane JP, Havel RJ. Disorders of the biogenesis and secretion of lipoproteins containing the B apolipoproteins. In: Scriver CR, Beaudet AL, Sly WS, Valle D, eds. The metabolic & molecular bases of inherited disease. 8th ed. Vol. 2. New York: McGraw-Hill, 2001:2717-52.
Seidman CE, Seidman JG. Hypertrophic cardiomyopathy. In: Scriver CR, Beaudet AL, Sly WS, Valle D, eds. The metabolic & molecular bases of inherited disease. 8th ed. Vol. 4. New York: McGraw-Hill, 2001:5433-50.

Sorted by citations

Cardiovascular Diseases (CVDs)
de la Zerda, A., & Wang, S. X. (2022) · doi:10.1002/9781118910573.ch5 · Cited by 1,281
Nrf2 and Oxidative Stress: A General Overview of Mechanisms and Implications in Human Disease
Ngo, V., & Duennwald, M. L. (2022) · Antioxidants · doi:10.3390/antiox11122345 · Cited by 1,130
A Tale of Coronary Artery Disease and Myocardial Infarction
Nabel, E. G., & Braunwald, E. (2012) · New England Journal of Medicine · doi:10.1056/nejmra1112570 · Cited by 1,024
Self-citation
Trends in insulin resistance: insights into mechanisms and therapeutic strategy
Li, M., Chi, X., Wang, Y., Setrerrahmane, S., Xie, W., & Xu, H. (2022) · Signal Transduction and Targeted Therapy · doi:10.1038/s41392-022-01073-0 · Cited by 939
Oral microbiota in human systematic diseases
Peng, X., Cheng, L., You, Y., Tang, C., Ren, B., Li, Y., Xu, X., & Zhou, X. (2022) · International Journal of Oral Science · doi:10.1038/s41368-022-00163-7 · Cited by 707

See all 432

Authors: Nabel, E. G.
Affiliations: National Institutes of Health (US)
Corresponding author: Nabel, Elizabeth G.
Venue: New England Journal of Medicine
Publisher: Massachusetts Medical Society
Published: 2003-07-03
Volume: 349
Issue: 1
Pages: 60-72
ISSN: 0028-4793 (ISSN-L)
1533-4406
DOI: 10.1056/nejmra035098
OpenAlex: W4245959283
Cited by: 431
References: 86
Citations by year: 2026: 11 · 2025: 22 · 2024: 45 · 2023: 37 · 2022: 26 · 2021: 20 · 2020: 9 · 2019: 9 · 2018: 14 · 2017: 10 · 2016: 17 · 2015: 15 · 2014: 19 · 2013: 14 · 2012: 14
FWCI: 2.11
Type: journal article
Language: en
Open access: bronze
doi.org
Locations: New England Journal of Medicine (publishedVersion)
PubMed (publishedVersion)
Topics: Life Sciences › Biochemistry, Genetics and Molecular Biology › Genetics › Genetic Associations and Epidemiology
Health Sciences › Medicine › Cardiology and Cardiovascular Medicine › Cardiovascular Health and Risk Factors
Health Sciences › Medicine › Cardiology and Cardiovascular Medicine › Cardiac electrophysiology and arrhythmias
Keywords: cardiovascular disease, genetic factors, heritability, coronary artery disease, hypertension, stroke, cardiovascular mortality, cardiovascular disease prevention, genomics
MeSH terms: Arrhythmias, Cardiac, Cardiovascular Diseases, Coronary Disease, Genetic Testing, Humans, Hypercholesterolemia, Hypertension, Cholesterol, LDL, Mutation, Cardiomyopathies, Polymorphism, Genetic, Thrombosis, Gene Expression Profiling

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

Cardiovascular Disease

Abstract

Overview

Integrity signals

Verification

Claims the paper makes

Claims other papers make about this one

Self-check

Citations

Cites

Cited by

Related

Metadata

Record

About these checks